FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1581536718> ?p ?o ?g. }

• W1581536718 startingPage "163" @default.
• W1581536718 abstract "ABSTRACT Defining the limits of biotechnology patents is one of the most Herculean tasks patent communities are faced with today. The topic was discussed by the Federal Trade Commission (FTC) and the National Academy of Sciences in their recent reports. Up to now, no coherent system has been developed that gives enough--but not too--much patent protection for DNA-related subject matter. This article analyzes the problem of patent breadth in the biotechnological field and outlines how to craft balanced patent protection for biotechnology inventions. Within the recommended system innovators would be rewarded adequately, but innovation would still be allowed without considerable delay and prohibitive costs. Based on a comparison of U.S. and European biotechnology patent law, the article first advocates for broad patent protection on DNA-related subject matter to create sufficient incentives for initial innovators to invest in costly biotechnological research. To simultaneously spur subsequent research, the article further proposes the introduction of a widespread compulsory licensing system on reasonable terms as a counterbalance. Thereby, the article opts for a compulsory licensing system that uses arbitration as an enforcement tool rather than traditional regulatory enforcement by the government. Arbitration is favored because it allows reconciliation of compulsory licensing with the principles of free trade. Moreover, arbitration makes compulsory licensing responsive to the peculiarities of the biotechnological area, which so strongly depends on patent protection. TABLE OF CONTENTS I. INTRODUCTION II. PATENTS ON BIOTECHNOLOGY INVENTIONS-- IMPORTANCE AND POLICY CONCERNS A. Biotechnology and Its Inventions 1. Biotechnology and Its Usefulness 2. What Are Biotechnology Inventions? 3. Why Are Patents on Biotechnology Inventions So Contentiously Discussed? B. Importance of Strong Biotechnology Patents C. Concerns that Exist as to (Broad) Patents on Biotechnology Inventions D. Consensus: Broad Patents and Broad Access Rights III. PATENTABILITY OF BIOTECHNOLOGY INVENTIONS IN U.S. AND EUROPEAN PATENT LAW A. Patentability of Biotechnology Inventions in the U.S. 1. Utility, 35 U.S.C. [section] 102 2. Nonobviousness, 35 U.S.C. [section] 103 3. Enabling, 35 U.S.C. [section] 112 4. Written Description, 35 U.S.C. [section] 112 5. Possible Impacts of the U.S. Patentability Standards B. Patentability of Biotechnology Inventions in Europe 1. The European Patent System 2. Patentability Standards Pursuant to the Biotechnology Directive a. Utility b. Inventive Step = Nonobviousness c. Enabling Disclosure and Patent Scope d. Assessment of the European Patenting Standard IV. GIVING ACCESS TO PATENTED INVENTIONS-- RESEARCH EXEMPTIONS AND COMPULSORY LICENSES A. Access Rights to Patented Biotechnology Inventions in U.S. Law B. Access Rights to Patented Biotechnology Inventions in Europe--A System to Adopt? 1. The Specific Access Rights in European Patent Law a. The Directive's Access Provisions b. Access Provisions in German Patent Law c. Access Provisions of the Proposal for a Regulation on the Community Patent 2. Disadvantages of the European Experimental Use Provisions 3. Disadvantages of the European Compulsory Licensing Models a. General Arguments Against Compulsory Licenses--Market Interventions b. Particular Drawbacks of the European Licensing Provisions 4. Conclusion: Adopting Experimental Use Provisions and/or Compulsory Licensing to Ensure Access? V. PROPOSAL FOR MODIFYING TRADITIONAL COMPULSORY LICENSING SCHEMES A. Substituting the Regulatory Nature of Compulsory Licensing 1. Patent Pooling as a Market-Based Solution to Grant Access 2. …" @default.
• W1581536718 created "2016-06-24" @default.
• W1581536718 creator A5024788227 @default.
• W1581536718 date "2004-11-01" @default.
• W1581536718 modified "2023-09-24" @default.
• W1581536718 title "Scope of Biotechnology Inventions in the United States and in Europe - Compulsory Licensing, Experimental Use and Arbitrtion: A Study of Patentability of DNA-Related Inventions with Special Emphasis on the Establishment of an Arbitration Based Compulsory Licensing System" @default.
• W1581536718 hasPublicationYear "2004" @default.
• W1581536718 type Work @default.
• W1581536718 sameAs 1581536718 @default.
• W1581536718 citedByCount "1" @default.
• W1581536718 countsByYear W15815367182012 @default.
• W1581536718 crossrefType "journal-article" @default.
• W1581536718 hasAuthorship W1581536718A5024788227 @default.
• W1581536718 hasConcept C144133560 @default.
• W1581536718 hasConcept C150903083 @default.
• W1581536718 hasConcept C160151201 @default.
• W1581536718 hasConcept C162324750 @default.
• W1581536718 hasConcept C175444787 @default.
• W1581536718 hasConcept C17744445 @default.
• W1581536718 hasConcept C190253527 @default.
• W1581536718 hasConcept C199360897 @default.
• W1581536718 hasConcept C199539241 @default.
• W1581536718 hasConcept C2777029862 @default.
• W1581536718 hasConcept C2777351106 @default.
• W1581536718 hasConcept C2778012447 @default.
• W1581536718 hasConcept C2779777834 @default.
• W1581536718 hasConcept C2780697943 @default.
• W1581536718 hasConcept C29122968 @default.
• W1581536718 hasConcept C2984145337 @default.
• W1581536718 hasConcept C2992860105 @default.
• W1581536718 hasConcept C34974158 @default.
• W1581536718 hasConcept C41008148 @default.
• W1581536718 hasConcept C47177190 @default.
• W1581536718 hasConcept C86803240 @default.
• W1581536718 hasConceptScore W1581536718C144133560 @default.
• W1581536718 hasConceptScore W1581536718C150903083 @default.
• W1581536718 hasConceptScore W1581536718C160151201 @default.
• W1581536718 hasConceptScore W1581536718C162324750 @default.
• W1581536718 hasConceptScore W1581536718C175444787 @default.
• W1581536718 hasConceptScore W1581536718C17744445 @default.
• W1581536718 hasConceptScore W1581536718C190253527 @default.
• W1581536718 hasConceptScore W1581536718C199360897 @default.
• W1581536718 hasConceptScore W1581536718C199539241 @default.
• W1581536718 hasConceptScore W1581536718C2777029862 @default.
• W1581536718 hasConceptScore W1581536718C2777351106 @default.
• W1581536718 hasConceptScore W1581536718C2778012447 @default.
• W1581536718 hasConceptScore W1581536718C2779777834 @default.
• W1581536718 hasConceptScore W1581536718C2780697943 @default.
• W1581536718 hasConceptScore W1581536718C29122968 @default.
• W1581536718 hasConceptScore W1581536718C2984145337 @default.
• W1581536718 hasConceptScore W1581536718C2992860105 @default.
• W1581536718 hasConceptScore W1581536718C34974158 @default.
• W1581536718 hasConceptScore W1581536718C41008148 @default.
• W1581536718 hasConceptScore W1581536718C47177190 @default.
• W1581536718 hasConceptScore W1581536718C86803240 @default.
• W1581536718 hasIssue "1" @default.
• W1581536718 hasLocation W15815367181 @default.
• W1581536718 hasOpenAccess W1581536718 @default.
• W1581536718 hasPrimaryLocation W15815367181 @default.
• W1581536718 hasRelatedWork W1478042587 @default.
• W1581536718 hasRelatedWork W1484937677 @default.
• W1581536718 hasRelatedWork W1487877986 @default.
• W1581536718 hasRelatedWork W1518474803 @default.
• W1581536718 hasRelatedWork W1544531133 @default.
• W1581536718 hasRelatedWork W168158381 @default.
• W1581536718 hasRelatedWork W2003144913 @default.
• W1581536718 hasRelatedWork W2016774233 @default.
• W1581536718 hasRelatedWork W2060303794 @default.
• W1581536718 hasRelatedWork W2104545498 @default.
• W1581536718 hasRelatedWork W2340663330 @default.
• W1581536718 hasRelatedWork W2346779665 @default.
• W1581536718 hasRelatedWork W2412219956 @default.
• W1581536718 hasRelatedWork W252452900 @default.
• W1581536718 hasRelatedWork W2547309731 @default.
• W1581536718 hasRelatedWork W2767869373 @default.
• W1581536718 hasRelatedWork W2994620986 @default.
• W1581536718 hasRelatedWork W3124282535 @default.
• W1581536718 hasRelatedWork W3141669411 @default.
• W1581536718 hasRelatedWork W82582239 @default.
• W1581536718 hasVolume "21" @default.
• W1581536718 isParatext "false" @default.
• W1581536718 isRetracted "false" @default.
• W1581536718 magId "1581536718" @default.
• W1581536718 workType "article" @default.